Economic Burden of Type 2 Diabetes Mellitus in India with Bibliometic and Quality Analysis of Studies: A Systematic Review
Background: Diabetes mellitus (DM) is a rapidly growing concern in India and globally, imposing a significant financial burden on patients. Despite its prevalence, cost-of-illness (COI) studies related to DM remain limited in India. Objective: To conduct a systematic review, bibliometric analysis, a...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-05-01
|
| Series: | Medical Journal of Dr. D.Y. Patil Vidyapeeth |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/mjdrdypu.mjdrdypu_77_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
Diabetes mellitus (DM) is a rapidly growing concern in India and globally, imposing a significant financial burden on patients. Despite its prevalence, cost-of-illness (COI) studies related to DM remain limited in India.
Objective:
To conduct a systematic review, bibliometric analysis, and quality evaluation and to determine the economic burden of T2DM in India from 2015 to 2019.
Methods:
The records were sourced from PubMed, the Cochrane Library, and Google Scholar. Bibliometric analysis focused on determining the average number of authors, pages, references, and citations. A 10-point scale assessed the quality of the included studies. The cost analysis categorized expenses into hospitalization, medications, consultations, investigations, other direct costs, indirect costs, non-medical costs, and the total costs reported in each study.
Results:
The systematic review generated 40 articles that were included in the study. The average number of authors, pages, references, and citations were 4.62, 7.17, 25.32, and 12.12, respectively. Eight journals were found to have an impact factor. It was found that 19 articles (47.5%) scored between 6 and 10 (i.e., for “yes”) while the remaining scored ≤5. The overall quality score for the articles was 209/400, that is, 52.25%. Annual and outpatient costs were the most commonly reported in 35% articles each, whereas the drug costs were the most frequently stated, that is, in 33 articles (82.5%). The median average annual costs were as follows- Hospitalization- ₹11011.62, Medicines-₹4772.42, Consultation- ₹1006.57, Investigations- ₹1211.6, Other- ₹1116.4, Indirect cost- ₹2041.71, Non-medical costs- ₹835.86, Total direct medical costs- ₹13466.34 and Total cost- ₹12391.84.
Conclusion:
A few articles were found to be published in internationally recognized journals. Quality of economic studies was not optimum in many articles. Drug costs were the most commonly reported costs. T2DM does impose a significant economic burden on patients. Further research is required for a better understanding of the area, and steps need to be taken to reduce the economic burden. |
|---|---|
| ISSN: | 2589-8302 2589-8310 |